Alkermes plc (NasdaqGS:ALKS) announces a share repurchase program. Under the program, the company will repurchase up to $400 million worth of its shares. The program does not have an expiration date.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.1 USD | -0.78% |
|
-3.41% | -13.12% |
06-17 | TD Cowen Initiates Alkermes at Buy With $34 Price Target | MT |
06-11 | Transcript : Alkermes plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.12% | 4.08B | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
+10.74% | 25.92B | |
-13.50% | 26.03B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B | |
-12.61% | 10.64B |
- Stock Market
- Equities
- ALKS Stock
- News Alkermes plc
- Alkermes plc announces an Equity Buyback for $400 million worth of its shares.